Contact

[email protected]
+1 941 755 6644

Follow

Info

Welcome to the Archer Pharmaceuticals website! Use this panel to navigate all the pages of the site.

News & Press Room
For media inquiries, please contact us at 941 755 6644.

For Immediate Release
Contact: Kristen Bridges (850) 222-2140
Tuesday, October 21, 2008

Sarasota, Fla. – A team of world-renowned scientists today announced the launch of Archer Pharmaceuticals, Inc., a new company that will use modern technologies for the identification of novel treatments for Alzheimer’s disease. Archer Pharmaceuticals, Inc., led by Chief Executive Officer Michael Mullan, M.B.B.S., Ph.D. and Chief Technical Officer Fiona Crawford, Ph.D., was created based on the groundbreaking research that their team has been conducting in Florida for the past five years.

Read More

Roskamp Institute scientists in Sarasota have a promising drug in trials in Europe. It switches the Alzheimer factory off.

The Sarasota Observer
SCIENCE & MEDICINE
By Heidi Kurpiela, Community Editor
Thursday, April 3, 2008

It starts as a protein, an organic compound of amino acids that is amorphous. Nebulous. Shaped like nothing, floating in the brain, passing through the blood barrier in small amounts. And like a pinch of vodka in soda water, they go unnoticed.

But over time and for whatever reason — scientists aren’t sure why —more and more of these proteins start accumulating in the brain, blanketing synapses in a sticky kind of plaque and like fine, fine hairs gathering in the bristles of a brush, the brain starts to clog with these things called beta-amyloids.

Under a microscope, the fibrous amyloids are no longer shapeless, nebulous things. They look like hairpins, twisty and stackable like Legos.

If this were a game of Tetris, you would work feverishly to clear the screen. This is an oversimplified metaphor for Alzheimer’s. But the description is not unlike what the scientists in white lab coats are doing on Whitfield Avenue in Sarasota.

Read More